Cocrystal Pharma, Inc.
- COCP
- NASDAQ
- Biotechnology
- Antiviral Therapeutics
- Hepatitis/Flu Inhibitors
$0.95
Today −7.20%Quote Oct 19, 2026, 08:00 PM UTC
−20.45%over the last month
Max drawdown −22.1%From 1-month high −22.1%3 months +1.8%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About Cocrystal Pharma
Cocrystal Pharma, Inc. (COCP) is a biotechnology firm dedicated to researching and advancing antiviral treatments for severe and/or persistent viral illnesses. The company leverages structure-based technologies to create new antiviral medications, primarily focusing on infections caused by the hepatitis C virus (HCV), influenza, coronaviruses, and noroviruses.
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Employees
10
Market value
$18.2M
Quote Oct 19
Floor
$0.94
0.4% below price
Resistance
$0.95
0.0% above price
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about COCPPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free